Mumbai | Emcure Pharmaceuticals Limited will launch its initial public offering (IPO) of Equity Shares on Wednesday, July 03, 2024. The price band has been set between ₹960 and ₹1008 per equity share, with a face value of ₹10 each. The bidding period will close on Friday, July 05, 2024.
Key details include:
Anchor Investor Bid/Offer Period: Tuesday, July 02, 2024
Bid/Offer Opening Date: Wednesday, July 03, 2024
Bid/Offer Closing Date: Friday, July 05, 2024
Minimum Bid: 14 Equity Shares and multiples of 14 Equity Shares thereafter
The offering comprises a fresh issue of equity shares and an offer for sale by existing shareholders. The proceeds will be used for repayment of certain borrowings and general corporate purposes. The equity shares will be listed on BSE and NSE.
For more details, refer to the Red Herring Prospectus and the price band advertisement.
Disclaimer: Potential investors should carefully consider the risks involved. The shares are being offered in compliance with U.S. regulations only to qualified institutional buyers.
Book Running Lead Managers: Kotak Mahindra Capital Company Limited, Axis Capital Limited, Jefferies India Private Limited, and J.P. Morgan India Private Limited.